The Wolf Administration is increasing access to treatment for people suffering with opioid use disorder. This tells the story of treatment within the state of Pennsylvania.

Governor's Goal that more Pennsylvanians should have access to primary and preventative care, be able to see a doctor when they are sick, and avoid costly trips to the emergency room. Increased health care access leads to better health outcomes, which are essential to a productive workforce and a thriving economy. When more Pennsylvanians have access to preventative health services, state-supported health care costs go down.

Governor's Goal - The opioid crisis is a public health emergency in Pennsylvania that is contributing to addiction, overdose emergencies, and deaths. The crisis is unprejudiced in its reach and devastation, impacting all areas of the state – including urban, suburban, and rural communities – and Pennsylvanians of all ages. However, Pennsylvania's experience shows that, with a proactive response, it is possible to prevent substance use disorders, increase access to treatment, and rescue those in dire need.

This dataset contains aggregate COVID-19 case counts and rates by date of first report for all counties in Pennsylvania and for the state as a whole. Counts include both confirmed and probable cases as defined by the Council of State and Territorial Epidemiologists (CSTE). At present, a person is counted as a case only once. Note that case counts by date of report are influenced by a variety of factors, including but not limited to testing availability, test ordering patterns (such as day of week patterns), labs reporting backlogged test results, and mass screenings in nursing homes, workplaces, schools, etc. Case reports received without a patient address are assigned to the county of the ordering provider or facility based on provider zip code. Cases reported with a residential address that does not match to a known postal address per the commonwealth geocoding service are assigned to a county based on the zip code of residence. Many zip codes cross county boundaries so there is some degree of misclassification of county. All counts may change on a daily basis due to reassignment of jurisdiction, removal of duplicate case reports, correction of errors, and other daily data cleaning activities. Downloaded data represents the best information available as of the previous day.

Data will be updated between 9-11 am every day.

This dataset contains aggregate death data at the state and county level for Pennsylvania residents. The data are displayed by county, date, death counts, averages, rates based on population. Pennsylvania statewide numbers are listed with Pennsylvania named as the county for the statewide totals. Do not add up the entire file (all rows) or counts will be duplicated.
Data will be updated between 9-11 am every day.

This dataset contains aggregate hospitalization data related to COVID-19 patient which includes availability of ICU beds, patients on ventilators, ventilators in use, and total patients hospitalized data at the state and county level for Pennsylvania residents.
Data will be updated between 9-11 am every day.

This dataset contains aggregate death data at the state and county level for Pennsylvania residents. The data are displayed by year, race/ethnicity, gender, age group and cause of death.

This page is part of the community impacts section and describes impacts on the economic cost of the opioid crisis by estimating lost wages.

This page describes information on the impacts of opioids on families and children.

View quarterly trends in Risky Prescribing Measures, including:
o Number/Rate of Individuals Seeing 5+ Prescribers and 5+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence.
o Number/Rate of Individuals Seeing 4+ Prescribers and 4+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence.
o Number/Rate of Individuals Seeing 3+ Prescribers and 3+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence.
o Number/Rate of Individuals with an Average Daily MME >50, >90 or >120: Average Daily MME is calculated as the sum of the total MME on each day in a time period based on all prescriptions an individual has filled divided by the number of days in the prescription(s). Measures include the number and rate of individuals prescribed greater than 50 MME per day, greater than 90 MME per day, or greater than 120 MME per day and is based on the patient’s county of residence.
o Number/Rate of Individuals with Overlapping Opioid/Benzodiazepine Prescriptions: Number of individuals receiving overlapping opioid and benzodiazepine prescriptions during a given quarter. This measure is based on the patients’ county of residence.
o Number/Rate of Individuals with > 30 Days of Overlapping Opioid/Benzodiazepine Prescriptions: Number and rate of individuals receiving overlapping opioid and benzodiazepine prescriptions for 30 days or more during a given quarter using state/county populations as denominators. This measure is based on the patients’ county of residence.
Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx